Braunstein et al create long-acting injectable drug delivery system for tuberculosis
August 11, 2022
Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read the full story here.